Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
ONLINE ARTICLE: Original Article

Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany

Retrospective Analysis of a Large Prescription Database

Helwig, Ulf MD*,†; Kostev, Karel PhD; Schmidt, Carsten MD§

Author Information
Journal of Clinical Gastroenterology: January 2021 - Volume 55 - Issue 1 - p e1-e7
doi: 10.1097/MCG.0000000000001323
  • Buy


Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.